Infokiri

Saatja: ECDC respiratory viruses <[email protected]>

Saadetud: 02.07.2024 18:11

Koopia: ECDC Info <[email protected]>

Teema: To OCPs for influenza for action: Virus characterisation/antiviral

susceptibility data call for southern hemisphere VCM report

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu

saatja korral palume linke ja faile mitte avada.

ECDC NORMAL

To: Operational Contact Points for Influenza (microbiology)

Cc: National Focal Points for Viral Respiratory Diseases,

National Coordinators

Dear colleagues,

The previous message had an error for the recordtypes used for SARI data

reporting.

For the epidemiological part of the WHO EURO/ECDC report ahead of the

Southern Hemisphere VCM, countries can report SARI data to either case-

base data (SARISURV and SARISURVDENOM) or aggregate data (INFLSARIAGGR).

Please do not hesitate to contact and in case you need assistance with

data reporting or have any questions.

Best regards,

The ECDC and WHO Europe Influenza teams

European Centre for Disease Prevention and Control (ECDC)

Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone &#43;46 (0)8 58 60 10 00

Follow ECDC on:

From: ECDC respiratory viruses Sent: Wednesday, June 26, 2024 2:45 PMCc:

ECDC Info &lt;[email protected]&gt;Subject: To OCPs for Influenza

for action: Virus characterisation/antiviral susceptibility data call for

southern hemisphere VCM report

To: Operational Contact Points for Influenza (microbiology)

Cc: National Focal Points for Viral Respiratory Diseases,

National Coordinators

Dear Colleagues,

We intend to prepare a summary report of the influenza antigenic,

genetic, and antiviral characterisation data with the available TESSy

data. This report will be shared with the GISRS network and submitted to

the WHO Consultation on the Composition of Influenza Virus Vaccines for

use in the 2025 Southern Hemisphere Influenza Season which will take

place 23-27 September 2024 (SH VCM).

The snapshot of the characterisation data reported to TESSy will be taken

on 22 August (with upload of data latest by 10:00 am CET 22 Aug). Please

upload the available data to TESSy in strain-based format in INFLANTIVIR

record type, and the sequences that you have in GISAID EpiFlu database.

Remember to release your sequences and use the Isolate ID, e.g.

EPI_ISL_16494781, and report for haemagglutinin gene in HAISD variable to

report to TESSy.

Please also report antiviral susceptibility data for oseltamivir,

zanamivir and baloxavir.

Additionally, please ensure that the data for the 2023/24 season is

complete, for the following record types and fields:

- INFLCLIN: intensity reporting

- INFLVIR or RESPIAGGR: sentinel and non-sentinel detections

and test of influenza, RSV and SARS-CoV-2

- INFLSARIAGGR: detections and tests per age group and per

pathogen

Please email (for EU/EEA countries) or (for countries outside EU/EEA),

if you need assistance with data reporting.

Additionally, we would like to remind you to share specimens/isolates

with a WHO Collaborating Centre by 14 August 2024. This will enable

Collaborating Centres to have a good set of results ahead of the SH VCM.

The criteria for selection of specimens to send to a WHO CC are described

in Operational Guidance for Sharing Seasonal Influenza Viruses with WHO

Collaborating Centres available on the public WHO web site at: .

Best regards,

The ECDC and WHO Europe Influenza teams

Confidentiality NoticeIf you are not the intended recipient of this

message, you are hereby kindly requested, to, consecutively, refrain from

disclosing its content to any third party, delete it and inform its

sender of the erroneous transmittal.